WellStar Health System Expands Use of Glytec’s eGlycemic Management System®
Summary
WALTHAM, Mass.--(BUSINESS WIRE)--Known nationally for innovative care models, WellStar Health System, in partnership with Glytec, is taking proactive measures to optimize glycemic management for hospitalized patients. “At any time, between a third and half of our critical care and emergency department patients require insulin therapy, so managing the timing and rate of intravenous infusions in a safe and effective manner is a top priority,” explains LeeAnna Spiva, assistant vice president nursing operations and practice for WellStar Health System. Evidence shows that by reducing variation and personalizing care in this way, patients have better outcomes, and that’s what matters most.” Members of Glytec’s Clinical Services and Quality Initiatives teams will work with WellStar’s clinical nurse specialists, physicians, pharmacists and other care team members to tailor workflows and order sets, and to configure key performance indicators and analytics to ensure that desired outcomes are realized though ongoing monitoring, measurement and response mechanisms. The company’s patented eGlycemic Management System® is the only FDA-cleared software-as-a-medical-device (SaMD) platform to enable the mass personalization of insulin across the continuum of care: inpatient, outpatient and virtual settings alike. Glytec offers several comprehensive programs combining evidence-based decision support technologies with expert professional services proven to aid providers in achieving best practices and standardization while reducing hyperglycemia, hypoglycemia, A1C, readmissions, length of stay and cost.